NEW YORK, Oct. 22, 2019 /PRNewswire/ -- Breast Cancer Therapeutics market worldwide is projected to grow by US$13.1 Billion, driven by a compounded growth of 9%. Hormone Drugs, one of the segments analyzed and sized in this study, displays the potential to grow at over 8.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$5.8 Billion by the year 2025, Hormone Drugs will bring in healthy gains adding significant momentum to global growth.
Read the full report: https://www.reportlinker.com/p05817675/?utm_source=PRN
- Representing the developed world, the United States will maintain a 7.6% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$452.2 Million to the region's size and clout in the next 5 to 6 years. Over US$380.9 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Hormone Drugs will reach a market size of US$322 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 13.4% over the next couple of years and add approximately US$3.7 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
- Competitors identified in this market include among others, AstraZeneca PLC; Celgene Corporation; Eisai Co., Ltd.; Eli Lilly and Company; Novartis International AG; Pfizer, Inc.; Roche Diagnostics; Sanofi; Teva Pharmaceutical Industries Ltd.
Read the full report: https://www.reportlinker.com/p05817675/?utm_source=PRN
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Breast Cancer Therapeutics Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Breast Cancer Therapeutics Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Breast Cancer Therapeutics Global Retrospective Market
Scenario in US$ Million by Region/Country: 2009-2017
Table 3: Breast Cancer Therapeutics Market Share Shift across
Key Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Hormone Drugs (Product) World Market by Region/Country
in US$ Million: 2018 to 2025
Table 5: Hormone Drugs (Product) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 6: Hormone Drugs (Product) Market Share Breakdown of
Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Chemotherapy Drugs (Product) Potential Growth Markets
Worldwide in US$ Million: 2018 to 2025
Table 8: Chemotherapy Drugs (Product) Historic Market
Perspective by Region/Country in US$ Million: 2009 to 2017
Table 9: Chemotherapy Drugs (Product) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Targeted Drug Therapy (Product) Geographic Market
Spread Worldwide in US$ Million: 2018 to 2025
Table 11: Targeted Drug Therapy (Product) Region Wise Breakdown
of Global Historic Demand in US$ Million: 2009 to 2017
Table 12: Targeted Drug Therapy (Product) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Breast Cancer Therapeutics Market Share (in %) by Company:
2019 & 2025
Table 13: United States Breast Cancer Therapeutics Market
Estimates and Projections in US$ Million by Product: 2018 to
2025
Table 14: Breast Cancer Therapeutics Market in the United
States by Product: A Historic Review in US$ Million for
2009-2017
Table 15: United States Breast Cancer Therapeutics Market Share
Breakdown by Product: 2009 VS 2019 VS 2025
CANADA
Table 16: Canadian Breast Cancer Therapeutics Market Estimates
and Forecasts in US$ Million by Product: 2018 to 2025
Table 17: Canadian Breast Cancer Therapeutics Historic Market
Review by Product in US$ Million: 2009-2017
Table 18: Breast Cancer Therapeutics Market in Canada:
Percentage Share Breakdown of Sales by Product for 2009, 2019,
and 2025
JAPAN
Table 19: Japanese Market for Breast Cancer Therapeutics:
Annual Sales Estimates and Projections in US$ Million by
Product for the Period 2018-2025
Table 20: Breast Cancer Therapeutics Market in Japan: Historic
Sales Analysis in US$ Million by Product for the Period
2009-2017
Table 21: Japanese Breast Cancer Therapeutics Market Share
Analysis by Product: 2009 VS 2019 VS 2025
CHINA
Table 22: Chinese Breast Cancer Therapeutics Market Growth
Prospects in US$ Million by Product for the Period 2018-2025
Table 23: Breast Cancer Therapeutics Historic Market Analysis
in China in US$ Million by Product: 2009-2017
Table 24: Chinese Breast Cancer Therapeutics Market by Product:
Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Breast Cancer Therapeutics Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Table 25: European Breast Cancer Therapeutics Market Demand
Scenario in US$ Million by Region/Country: 2018-2025
Table 26: Breast Cancer Therapeutics Market in Europe: A
Historic Market Perspective in US$ Million by Region/Country
for the Period 2009-2017
Table 27: European Breast Cancer Therapeutics Market Share
Shift by Region/Country: 2009 VS 2019 VS 2025
Table 28: European Breast Cancer Therapeutics Market Estimates
and Forecasts in US$ Million by Product: 2018-2025
Table 29: Breast Cancer Therapeutics Market in Europe in US$
Million by Product: A Historic Review for the Period 2009-2017
Table 30: European Breast Cancer Therapeutics Market Share
Breakdown by Product: 2009 VS 2019 VS 2025
FRANCE
Table 31: Breast Cancer Therapeutics Market in France by
Product: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 32: French Breast Cancer Therapeutics Historic Market
Scenario in US$ Million by Product: 2009-2017
Table 33: French Breast Cancer Therapeutics Market Share
Analysis by Product: 2009 VS 2019 VS 2025
GERMANY
Table 34: Breast Cancer Therapeutics Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Product for
the Period 2018-2025
Table 35: German Breast Cancer Therapeutics Historic Market
Analysis in US$ Million by Product: 2009-2017
Table 36: German Breast Cancer Therapeutics Market Share
Breakdown by Product: 2009 VS 2019 VS 2025
ITALY
Table 37: Italian Breast Cancer Therapeutics Market Growth
Prospects in US$ Million by Product for the Period 2018-2025
Table 38: Breast Cancer Therapeutics Historic Market Analysis
in Italy in US$ Million by Product: 2009-2017
Table 39: Italian Breast Cancer Therapeutics Market by Product:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 40: United Kingdom Market for Breast Cancer Therapeutics:
Annual Sales Estimates and Projections in US$ Million by
Product for the Period 2018-2025
Table 41: Breast Cancer Therapeutics Market in the United
Kingdom: Historic Sales Analysis in US$ Million by Product for
the Period 2009-2017
Table 42: United Kingdom Breast Cancer Therapeutics Market
Share Analysis by Product: 2009 VS 2019 VS 2025
SPAIN
Table 43: Spanish Breast Cancer Therapeutics Market Estimates
and Forecasts in US$ Million by Product: 2018 to 2025
Table 44: Spanish Breast Cancer Therapeutics Historic Market
Review by Product in US$ Million: 2009-2017
Table 45: Breast Cancer Therapeutics Market in Spain:
Percentage Share Breakdown of Sales by Product for 2009, 2019,
and 2025
RUSSIA
Table 46: Russian Breast Cancer Therapeutics Market Estimates
and Projections in US$ Million by Product: 2018 to 2025
Table 47: Breast Cancer Therapeutics Market in Russia by
Product: A Historic Review in US$ Million for 2009-2017
Table 48: Russian Breast Cancer Therapeutics Market Share
Breakdown by Product: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 49: Rest of Europe Breast Cancer Therapeutics Market
Estimates and Forecasts in US$ Million by Product: 2018-2025
Table 50: Breast Cancer Therapeutics Market in Rest of Europe
in US$ Million by Product: A Historic Review for the Period
2009-2017
Table 51: Rest of Europe Breast Cancer Therapeutics Market
Share Breakdown by Product: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 52: Asia-Pacific Breast Cancer Therapeutics Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 53: Breast Cancer Therapeutics Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2009-2017
Table 54: Asia-Pacific Breast Cancer Therapeutics Market Share
Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 55: Breast Cancer Therapeutics Market in Asia-Pacific by
Product: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 56: Asia-Pacific Breast Cancer Therapeutics Historic
Market Scenario in US$ Million by Product: 2009-2017
Table 57: Asia-Pacific Breast Cancer Therapeutics Market Share
Analysis by Product: 2009 VS 2019 VS 2025
AUSTRALIA
Table 58: Breast Cancer Therapeutics Market in Australia:
Recent Past, Current and Future Analysis in US$ Million by
Product for the Period 2018-2025
Table 59: Australian Breast Cancer Therapeutics Historic Market
Analysis in US$ Million by Product: 2009-2017
Table 60: Australian Breast Cancer Therapeutics Market Share
Breakdown by Product: 2009 VS 2019 VS 2025
INDIA
Table 61: Indian Breast Cancer Therapeutics Market Estimates
and Forecasts in US$ Million by Product: 2018 to 2025
Table 62: Indian Breast Cancer Therapeutics Historic Market
Review by Product in US$ Million: 2009-2017
Table 63: Breast Cancer Therapeutics Market in India:
Percentage Share Breakdown of Sales by Product for 2009, 2019,
and 2025
SOUTH KOREA
Table 64: Breast Cancer Therapeutics Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
Product for the Period 2018-2025
Table 65: South Korean Breast Cancer Therapeutics Historic
Market Analysis in US$ Million by Product: 2009-2017
Table 66: Breast Cancer Therapeutics Market Share Distribution
in South Korea by Product: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 67: Rest of Asia-Pacific Market for Breast Cancer
Therapeutics: Annual Sales Estimates and Projections in US$
Million by Product for the Period 2018-2025
Table 68: Breast Cancer Therapeutics Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Product
for the Period 2009-2017
Table 69: Rest of Asia-Pacific Breast Cancer Therapeutics
Market Share Analysis by Product: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 70: Latin American Breast Cancer Therapeutics Market
Trends by Region/Country in US$ Million: 2018-2025
Table 71: Breast Cancer Therapeutics Market in Latin America in
US$ Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 72: Latin American Breast Cancer Therapeutics Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 73: Latin American Breast Cancer Therapeutics Market
Growth Prospects in US$ Million by Product for the Period
2018-2025
Table 74: Breast Cancer Therapeutics Historic Market Analysis
in Latin America in US$ Million by Product: 2009-2017
Table 75: Latin American Breast Cancer Therapeutics Market by
Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
Table 76: Argentinean Breast Cancer Therapeutics Market
Estimates and Forecasts in US$ Million by Product: 2018-2025
Table 77: Breast Cancer Therapeutics Market in Argentina in US$
Million by Product: A Historic Review for the Period 2009-2017
Table 78: Argentinean Breast Cancer Therapeutics Market Share
Breakdown by Product: 2009 VS 2019 VS 2025
BRAZIL
Table 79: Breast Cancer Therapeutics Market in Brazil by
Product: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 80: Brazilian Breast Cancer Therapeutics Historic Market
Scenario in US$ Million by Product: 2009-2017
Table 81: Brazilian Breast Cancer Therapeutics Market Share
Analysis by Product: 2009 VS 2019 VS 2025
MEXICO
Table 82: Breast Cancer Therapeutics Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by Product for
the Period 2018-2025
Table 83: Mexican Breast Cancer Therapeutics Historic Market
Analysis in US$ Million by Product: 2009-2017
Table 84: Mexican Breast Cancer Therapeutics Market Share
Breakdown by Product: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 85: Rest of Latin America Breast Cancer Therapeutics
Market Estimates and Projections in US$ Million by Product:
2018 to 2025
Table 86: Breast Cancer Therapeutics Market in Rest of Latin
America by Product: A Historic Review in US$ Million for
2009-2017
Table 87: Rest of Latin America Breast Cancer Therapeutics
Market Share Breakdown by Product: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 88: The Middle East Breast Cancer Therapeutics Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 89: Breast Cancer Therapeutics Market in the Middle East
by Region/Country in US$ Million: 2009-2017
Table 90: The Middle East Breast Cancer Therapeutics Market
Share Breakdown by Region/Country: 2009, 2019, and 2025
Table 91: The Middle East Breast Cancer Therapeutics Market
Estimates and Forecasts in US$ Million by Product: 2018 to 2025
Table 92: The Middle East Breast Cancer Therapeutics Historic
Market by Product in US$ Million: 2009-2017
Table 93: Breast Cancer Therapeutics Market in the Middle East:
Percentage Share Breakdown of Sales by Product for 2009, 2019,
and 2025
IRAN
Table 94: Iranian Market for Breast Cancer Therapeutics: Annual
Sales Estimates and Projections in US$ Million by Product for
the Period 2018-2025
Table 95: Breast Cancer Therapeutics Market in Iran: Historic
Sales Analysis in US$ Million by Product for the Period
2009-2017
Table 96: Iranian Breast Cancer Therapeutics Market Share
Analysis by Product: 2009 VS 2019 VS 2025
ISRAEL
Table 97: Israeli Breast Cancer Therapeutics Market Estimates
and Forecasts in US$ Million by Product: 2018-2025
Table 98: Breast Cancer Therapeutics Market in Israel in US$
Million by Product: A Historic Review for the Period 2009-2017
Table 99: Israeli Breast Cancer Therapeutics Market Share
Breakdown by Product: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 100: Saudi Arabian Breast Cancer Therapeutics Market
Growth Prospects in US$ Million by Product for the Period
2018-2025
Table 101: Breast Cancer Therapeutics Historic Market Analysis
in Saudi Arabia in US$ Million by Product: 2009-2017
Table 102: Saudi Arabian Breast Cancer Therapeutics Market by
Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 103: Breast Cancer Therapeutics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Product for the Period 2018-2025
Table 104: United Arab Emirates Breast Cancer Therapeutics
Historic Market Analysis in US$ Million by Product: 2009-2017
Table 105: Breast Cancer Therapeutics Market Share Distribution
in United Arab Emirates by Product: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 106: Breast Cancer Therapeutics Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Million
by Product for the Period 2018-2025
Table 107: Rest of Middle East Breast Cancer Therapeutics
Historic Market Analysis in US$ Million by Product: 2009-2017
Table 108: Rest of Middle East Breast Cancer Therapeutics
Market Share Breakdown by Product: 2009 VS 2019 VS 2025
AFRICA
Table 109: African Breast Cancer Therapeutics Market Estimates
and Projections in US$ Million by Product: 2018 to 2025
Table 110: Breast Cancer Therapeutics Market in Africa by
Product: A Historic Review in US$ Million for 2009-2017
Table 111: African Breast Cancer Therapeutics Market Share
Breakdown by Product: 2009 VS 2019 VS 2025
IV. COMPETITION
ASTRAZENECA PLC
CELGENE CORPORATION
EISAI CO.
ELI LILLY AND COMPANY
NOVARTIS INTERNATIONAL AG
PFIZER
ROCHE DIAGNOSTICS
SANOFI
TEVA PHARMACEUTICAL INDUSTRIES
V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05817675/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article